Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumors × Immune Checkpoint Inhibitors × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 2 Solid Cancers 2 Neoplasms 2 Melanoma 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcopenia 1 SCLC 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Immune-Related Adverse Events 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

trifluridine tipiracil drug combination 1 tislelizumab 1 sotorasib 1 pembrolizumab 1 palbociclib 1 Pemetrexed 1 Panitumumab 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fulvestrant 1 Fluorouracil 1 Drug Therapy 1 Docetaxel 1 Cetuximab 1 Carboplatin 1 Bevacizumab 1 ASP1570 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡